see full chart at www.tradingview.com/u/WallSt007
GSK
Entry $39.70
Target 1 $42.45
Target 2 $45.50
Target 3 $48
stoploss 38.70
Why this play?
There are 4 general approaches to the Covid vaccine.
1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax)
2.Coronavirus proteins themselves, produced industrially in outside cell cultures,
which will be recognized as foreign matter in the blood. (GlaxoSmithKline/Sanofi, Novavax)
3.A different virus (human or ape adenovirus, measles, etc) that is engineered
to include genetic components coding for the SARS-CoV-2 spike proteins,
which causes the body to then produce them. (CanSino, Oxford, J&J,
Merck/Themis)
4.DNA or RNA that will be taken up by cells and will cause them to make
coronavirus proteins. (Moderna, Innovio,
BioNTech/Pfizer)
GSK is #2, there is only 1 other big company doing this approach and that is NVAX.
We are betting on the fact that if they are successful, they could have super run like NVAX.
What is GSk?
www.gsk.com/en-gb/me...t-against-2019-ncov/
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
GSK
Entry $39.70
Target 1 $42.45
Target 2 $45.50
Target 3 $48
stoploss 38.70
Why this play?
There are 4 general approaches to the Covid vaccine.
1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax)
2.Coronavirus proteins themselves, produced industrially in outside cell cultures,
which will be recognized as foreign matter in the blood. (GlaxoSmithKline/Sanofi, Novavax)
3.A different virus (human or ape adenovirus, measles, etc) that is engineered
to include genetic components coding for the SARS-CoV-2 spike proteins,
which causes the body to then produce them. (CanSino, Oxford, J&J,
Merck/Themis)
4.DNA or RNA that will be taken up by cells and will cause them to make
coronavirus proteins. (Moderna, Innovio,
BioNTech/Pfizer)
GSK is #2, there is only 1 other big company doing this approach and that is NVAX.
We are betting on the fact that if they are successful, they could have super run like NVAX.
What is GSk?
www.gsk.com/en-gb/me...t-against-2019-ncov/
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Trade closed: target reached:
Target 1 reached a while back.
Comment:
we are getting re-entry again.
If you appreciate my technical analysis and want to tip me
---> www.patreon.com/WallSt
Also don't forget to check my other pages beacons.ai/diywallst
---> www.patreon.com/WallSt
Also don't forget to check my other pages beacons.ai/diywallst